Search research articles
Contact Us
Filters
Showing results (1-10 of 121) with videos related to
Page
of 13
Sort By:
Drugs in R&D
|
March 3, 2019
S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study
Marino Venerito
Helicobacter
|
July 17, 2010
Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers
Marino Venerito, Peter Malfertheiner
Deutsche Medizinische Wochenschrift (1946)
|
August 28, 2022
[Peptic ulcer disease and H. pylori gastritis: key advances in clinical management]
Cornelia Schneider, Marino Venerito
Digestive Diseases (Basel, Switzerland)
|
December 23, 2014
Preneoplastic conditions in the stomach: always a point of no return?
Marino Venerito, Peter Malfertheiner
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies
Marino Venerito, Thomas Wex, Peter Malfertheiner
MMW Fortschritte Der Medizin
|
July 22, 2016
[Prevention, early diagnosis and therapy of gastric cancer]
Marino Venerito, Riccardo Vasapolli, Peter Malfertheiner
Helicobacter
|
September 10, 2013
Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects
Marino Venerito, Michael Selgrad, Peter Malfertheiner
Deutsche Medizinische Wochenschrift (1946)
|
April 11, 2022
[Clinical management of autoimmune gastritis]
Marino Venerito, Sabrina Sulzer, Dörthe Jechorek
Expert Review of Gastroenterology & Hepatology
|
December 2, 2015
Helicobacter pylori screening: options and challenges
Marino Venerito, Elisabetta Goni, Peter Malfertheiner
Current Treatment Options in Gastroenterology
|
November 12, 2018
Helicobacter pylori Infection: New Facts in Clinical Management
Peter Malfertheiner, Marino Venerito, Christian Schulz
Page
of 13
Search research articles
Search
Showing results (1-10 of 121) with videos related to
Sort By:
Page
of 13
Drugs in R&D
|
March 3, 2019
S-1 in Patients with Advanced Esophagogastric Adenocarcinoma: Results from the Safety Compliance Observatory on Oral fluoroPyrimidines (SCOOP) Study
Marino Venerito
Helicobacter
|
July 17, 2010
Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers
Marino Venerito, Peter Malfertheiner
Deutsche Medizinische Wochenschrift (1946)
|
August 28, 2022
[Peptic ulcer disease and H. pylori gastritis: key advances in clinical management]
Cornelia Schneider, Marino Venerito
Digestive Diseases (Basel, Switzerland)
|
December 23, 2014
Preneoplastic conditions in the stomach: always a point of no return?
Marino Venerito, Peter Malfertheiner
Pharmaceuticals (Basel, Switzerland)
|
October 8, 2016
Nonsteroidal Anti-Inflammatory Drug-Induced Gastroduodenal Bleeding: Risk Factors and Prevention Strategies
Marino Venerito, Thomas Wex, Peter Malfertheiner
MMW Fortschritte Der Medizin
|
July 22, 2016
[Prevention, early diagnosis and therapy of gastric cancer]
Marino Venerito, Riccardo Vasapolli, Peter Malfertheiner
Helicobacter
|
September 10, 2013
Helicobacter pylori: gastric cancer and extragastric malignancies - clinical aspects
Marino Venerito, Michael Selgrad, Peter Malfertheiner
Deutsche Medizinische Wochenschrift (1946)
|
April 11, 2022
[Clinical management of autoimmune gastritis]
Marino Venerito, Sabrina Sulzer, Dörthe Jechorek
Expert Review of Gastroenterology & Hepatology
|
December 2, 2015
Helicobacter pylori screening: options and challenges
Marino Venerito, Elisabetta Goni, Peter Malfertheiner
Current Treatment Options in Gastroenterology
|
November 12, 2018
Helicobacter pylori Infection: New Facts in Clinical Management
Peter Malfertheiner, Marino Venerito, Christian Schulz
Page
of 13